SNTI Valuation

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

SNTI Relative Valuation

SNTI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SNTI is overvalued; if below, it's undervalued.

Historical Valuation

Senti Biosciences Inc (SNTI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 17.27 is considered Undervalued compared with the five-year average of 13.83. The fair price of Senti Biosciences Inc (SNTI) is between 32.10 to 33.80 according to relative valuation methord. Compared to the current price of 3.32 USD , Senti Biosciences Inc is Undervalued By 89.66%.

Relative Value

Fair Zone

32.10-33.80

Current Price：3.32

89.66%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.61

P/B

Median3y

0.42

Median5y

-0.11

-47.98

FCF Yield

Median3y

-232.25

Median5y

-179.28

Competitors Valuation Multiple

The average P/S ratio for SNTI's competitors is 724.53, providing a benchmark for relative valuation. Senti Biosciences Inc Corp (SNTI) exhibits a P/S ratio of 17.27, which is -97.62% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SNTI.O

Senti Biosciences Inc

17.27

Average P/S: 724.53

86.56M